Jie Lin, Zhan Zhang, Qiang Zhou, Jiayi Shi, Wanqing Li, Sen Lin, Hu Tang, Zheyu Zhang, Tianfeng Chen, Xiaojun Cai, Longhe Cao
{"title":"Unraveling the Causal Relationship Between 731 Immunocyte Phenotypes and Asthma Risk: A Bidirectional Mendelian Randomization Analysis","authors":"Jie Lin, Zhan Zhang, Qiang Zhou, Jiayi Shi, Wanqing Li, Sen Lin, Hu Tang, Zheyu Zhang, Tianfeng Chen, Xiaojun Cai, Longhe Cao","doi":"10.1002/tox.24506","DOIUrl":null,"url":null,"abstract":"Growing evidence suggests an association between various immune cell phenotypes and the development of asthma. However, it is still not entirely clear whether specific immune cell phenotypes might causally contribute to the risk of asthma. Despite further studies required to validate this claim, our study delves deeper into explaining this relationship and paving the way toward new therapeutic approaches. Our initial aim is to reveal the causal relationship between 731 immunocyte phenotypes and asthma; a bidirectional Mendelian randomization (MR) analysis was performed. We have investigated 731 immunocyte phenotypes in asthma, using a summary of previously published GWAS. Conducting an MR analysis, we have interpreted the potential causative relationship between them. Our analytical approaches included inverse variance‐weighted average, weighted median (WM) modeling, and pattern‐based approaches. To ensure the robustness and accuracy of our findings, we conducted sensitivity analyses employing MR‐PRESSO, Cochran's <jats:italic>Q</jats:italic> test, leave‐one‐out, and MR‐Egger approaches. Additionally, we conducted a reverse MR analysis to examine potential reverse causality. Our study revealed 43 immunophenotypes with a causal connection to asthma risk. Following Bonferroni correction and sensitivity analysis, we have identified four immunophenotypes with strong causal associations and reliability, them being: HLA DR on DC (95% CI: 1.0008–1.0014, <jats:italic>p</jats:italic> = 4.26 × 10<jats:sup>−6</jats:sup>, FDR = 2.21 × 10<jats:sup>−8</jats:sup>), CD8 on CD28− CD8br (95% CI: 1.0007–1.0020, <jats:italic>p</jats:italic> = 4.01 × 10<jats:sup>−5</jats:sup>,FDR = 5.70 × 10<jats:sup>−4</jats:sup>), CD62L on monocyte (95% CI: 0.9985–0.9995,<jats:italic>p</jats:italic> = 1.06 × 10<jats:sup>−4</jats:sup>,FDR = 9.20 × 10<jats:sup>−4</jats:sup>), CD8br% leukocyte (95% CI: 1.0006–1.0019,<jats:italic>p</jats:italic> = 1.07 × 10<jats:sup>−4</jats:sup>,FDR = 1.14 × 10<jats:sup>−3</jats:sup>). We have confirmed the large co‐inheritance of all these immunophenotypes, which suggests a contribution to asthma development. In addition, reverse MR confirmed that asthma and immune cell phenotypes lack a causal association between them. Our study provides evidence of different immune phenotypes, which are either beneficial or detrimental to asthma. Given the fact that asthma is a broad disease and contains complex immune mechanisms, this research may offer improved outcomes and long‐term asthma treatment strategies.","PeriodicalId":11756,"journal":{"name":"Environmental Toxicology","volume":"4 1","pages":""},"PeriodicalIF":4.4000,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Environmental Toxicology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/tox.24506","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENVIRONMENTAL SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Growing evidence suggests an association between various immune cell phenotypes and the development of asthma. However, it is still not entirely clear whether specific immune cell phenotypes might causally contribute to the risk of asthma. Despite further studies required to validate this claim, our study delves deeper into explaining this relationship and paving the way toward new therapeutic approaches. Our initial aim is to reveal the causal relationship between 731 immunocyte phenotypes and asthma; a bidirectional Mendelian randomization (MR) analysis was performed. We have investigated 731 immunocyte phenotypes in asthma, using a summary of previously published GWAS. Conducting an MR analysis, we have interpreted the potential causative relationship between them. Our analytical approaches included inverse variance‐weighted average, weighted median (WM) modeling, and pattern‐based approaches. To ensure the robustness and accuracy of our findings, we conducted sensitivity analyses employing MR‐PRESSO, Cochran's Q test, leave‐one‐out, and MR‐Egger approaches. Additionally, we conducted a reverse MR analysis to examine potential reverse causality. Our study revealed 43 immunophenotypes with a causal connection to asthma risk. Following Bonferroni correction and sensitivity analysis, we have identified four immunophenotypes with strong causal associations and reliability, them being: HLA DR on DC (95% CI: 1.0008–1.0014, p = 4.26 × 10−6, FDR = 2.21 × 10−8), CD8 on CD28− CD8br (95% CI: 1.0007–1.0020, p = 4.01 × 10−5,FDR = 5.70 × 10−4), CD62L on monocyte (95% CI: 0.9985–0.9995,p = 1.06 × 10−4,FDR = 9.20 × 10−4), CD8br% leukocyte (95% CI: 1.0006–1.0019,p = 1.07 × 10−4,FDR = 1.14 × 10−3). We have confirmed the large co‐inheritance of all these immunophenotypes, which suggests a contribution to asthma development. In addition, reverse MR confirmed that asthma and immune cell phenotypes lack a causal association between them. Our study provides evidence of different immune phenotypes, which are either beneficial or detrimental to asthma. Given the fact that asthma is a broad disease and contains complex immune mechanisms, this research may offer improved outcomes and long‐term asthma treatment strategies.
期刊介绍:
The journal publishes in the areas of toxicity and toxicology of environmental pollutants in air, dust, sediment, soil and water, and natural toxins in the environment.Of particular interest are:
Toxic or biologically disruptive impacts of anthropogenic chemicals such as pharmaceuticals, industrial organics, agricultural chemicals, and by-products such as chlorinated compounds from water disinfection and waste incineration;
Natural toxins and their impacts;
Biotransformation and metabolism of toxigenic compounds, food chains for toxin accumulation or biodegradation;
Assays of toxicity, endocrine disruption, mutagenicity, carcinogenicity, ecosystem impact and health hazard;
Environmental and public health risk assessment, environmental guidelines, environmental policy for toxicants.